Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

george_masoura_drugdev_vice_president_business_development_europe_0

DrugDev signs up George Masoura as Vice President of Business Development

March 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment

DrugDev has announced the appointment of George Masoura who has joined the company as Vice President, Business Development, Europe to …
Appointment
shutterstock_146497481

GSK and Regeneron partner with Biobank to analyse 500,000 genetic profiles

March 23, 2017 Research and Development Biobank, GSK, Regeneron

GlaxoSmithKline and Regeneron Pharmaceuticals are to band together in a joint effort with UK Biobank – “the world’s most detailed …
News
shire_image

Shire’s drug picked up from Baxalta given fast track designation

March 23, 2017 Research and Development, Sales and Marketing Shire, rare diseases

Shire has announced that its drug, SHP655, has received a fast track designation based on pre-clinical trials and positive results …
News
fda2outsideweb

FDA approves first Parkinson’s treatment in a decade

March 22, 2017 Research and Development, Sales and Marketing FDA, Parkinson's, Xadago

The FDA has approved Xadago (safinamide) as a supplementary treatment for Parkinson’s in patients currently taking levodopa/carbidopa and who are …
News
shutterstock_292920209

Alternative treatment cures rare blood disease for first time

March 22, 2017 Research and Development congenital dyserythropoietic anaemia

A Chicago man has become the first person ever documented to be cured of congenital dyserythropoietic anaemia (CDA), a rare …
News
gsk_boronia_australia

GSK begins £92 million expansion of UK site

March 22, 2017 Manufacturing and Production, Research and Development GSK, UK

GSK has officially broken ground on the expansion of its site in County Durham. The expanded site will be an …
News
heartbeat

Novartis heart failure drug sinks at Phase 3 trials

March 22, 2017 Research and Development Acute heart failure, Novartis, serelaxin

Novartis’ serelaxin was once thought to be the major hope for its cardiovascular pipeline – analysts projected it to become …
News

Novartis’ psoriasis drug allows some patients to go into remission

March 21, 2017 Research and Development Cosentyx, Novartis, psoriasis

Novartis released data on patient’s reaction to Cosentyx for the treatment of psoriasis, finding that as many as 21% of …
News
shutterstock_291014192

Asia-Pacific NSCLC market to more than double to $6.2bn by 2023

March 21, 2017 Manufacturing and Production, Research and Development, Sales and Marketing BMS, Eli Lilly, MSD, NSCLC, Yervoy, keytruda, opdivo

New research from intelligence provider GBI Research has indicated that the non-small cell lung cancer (NSCLC) market in the Asia-Pacific …
News
lilly_scientists

Lilly’s breast cancer drug meets primary endpoint

March 21, 2017 Manufacturing and Production, Research and Development CDK 4/6 inhibitors, Eli Lilly, abemaciclib

Eli Lilly has announced that its trial of abemaciclib, in combination with fulvestrant, had met its primary endpoint of progression-free …
News

India aims to become “a global innovation hub” for biotechs by 2020

March 21, 2017 Manufacturing and Production, Research and Development India, biotech

The Indian Government has announced its intention to transform the nation into a hub for global biotech activity via its …
News
shutterstock_311949818

Genentech plans second Phase 3 Alzheimer’s trial following endpoint failures

March 20, 2017 Research and Development, Sales and Marketing Alzheimer's, Genentech, Roche

Genentech, Roche’s biotech group, has announced its plans to conduct a second Phase 3 study for crenezumab, its anti-Abeta antibody …
News
pulmocide-logo

UK biotech Pulmocide secures $30m for inhalable lung disease therapies

March 20, 2017 Research and Development, Sales and Marketing pulmocide, pulmonary aspergillosis, respiratory syncytial virus

Pulmocide, a UK biotech run by a former GlaxoSmithKline scientists and based in London, has secured $30.4 million in Series …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

As another week comes and goes, waves were sent through the industry as Trump announced his pick as the new …
News
anirvan_ghosh

Biogen swoops to appoint Ex-Roche Vice President

March 16, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen

Biogen have appointed Anirvan Ghosh to the position of Senior Vice President of research and Early Development. Ghosh is slated …
Appointment
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026